Stock listing
BX Swiss:DUL Alnylam Pharmaceuticals, Inc. Aktie
Swiss listing (BX Swiss) of Alnylam Pharmaceuticals, Inc. · home listing NASDAQ:ALNY
Follow Alnylam Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:ALNY
$158.00 USD -7.00 (-4.2%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:ALNY
- Day range
- $156.06 – $163.90 USDNov 2, 2026
- Volume
- 4.76M sharesNov 2, 2026
- Market cap
- $21.14B USDAt the close on Nov 2, 2026 · price × 133.8M shares outstanding
- 52-week range
- $156.06 – $479.79 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $417.1M USDMedian day 1.51M shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ALNY · Home | $158.00 USD | -7.00 (-4.2%) | 4,762,079 | $163.08 | $163.90 | $156.06 | $165.00 | Close on Nov 2, 2026 |
| B3:A1LN34 | 60.76 BRL | +4.72 (+8.4%) | 200 | 60.76 | 60.76 | 60.76 | 56.04 | Close on Oct 27, 2026 |
| LSE:0HD2 | $225.86 USD | -0.69 (-0.3%) | 220 | $229.35 | $231.98 | $223.80 | $226.55 | Close on Oct 27, 2026 |
| Frankfurt:DUL | €146.55 EUR | -55.85 (-27.6%) | — | €157.75 | €158.80 | €146.55 | €202.40 | Close on Oct 30, 2026 |
| Munich:DUL | €204.25 EUR | +2.15 (+1.1%) | — | €204.25 | €204.25 | €204.25 | €202.10 | Close on Oct 27, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:ALNY · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $158.00 | -7.00 | -4.2% | $163.08 | $163.90 | $156.06 | 4,762,079 | |
| $165.00 | -9.00 | -5.2% | $172.70 | $180.61 | $163.30 | 7,054,900 | |
| $174.00 | -58.40 | -25.1% | $185.59 | $202.37 | $172.31 | 11,800,000 | |
| $232.40 | +5.61 | +2.5% | $222.72 | $232.88 | $220.00 | 1,943,900 | |
| $226.79 | -0.87 | -0.4% | $225.00 | $228.49 | $222.82 | 1,603,500 | |
| $227.66 | +3.63 | +1.6% | $226.24 | $232.48 | $224.10 | 1,436,900 | |
| $224.03 | -3.25 | -1.4% | $227.28 | $229.39 | $222.00 | 1,055,900 | |
| $227.28 | +2.18 | +1.0% | $224.92 | $229.82 | $223.76 | 2,211,900 | |
| $225.10 | -5.61 | -2.4% | $227.86 | $230.84 | $224.88 | 1,181,000 | |
| $230.71 | -2.58 | -1.1% | $237.73 | $238.96 | $229.54 | 1,505,200 | |
| $233.29 | +1.46 | +0.6% | $232.65 | $236.54 | $231.26 | 1,344,100 | |
| $231.83 | -2.20 | -0.9% | $235.18 | $237.98 | $231.29 | 1,404,800 | |
| $234.03 | +9.56 | +4.3% | $230.00 | $234.30 | $228.12 | 1,257,400 | |
| $224.47 | +0.65 | +0.3% | $224.49 | $229.56 | $222.25 | 1,105,600 | |
| $223.82 | -3.20 | -1.4% | $228.93 | $229.53 | $221.56 | 1,119,000 | |
| $227.02 | -5.66 | -2.4% | $233.13 | $233.60 | $226.35 | 916,900 | |
| $232.68 | +8.15 | +3.6% | $224.74 | $232.94 | $222.71 | 959,400 | |
| $224.53 | +0.12 | +0.1% | $222.03 | $225.90 | $218.39 | 1,771,700 | |
| $224.41 | +0.47 | +0.2% | $224.39 | $230.42 | $222.46 | 1,064,100 | |
| $223.94 | +4.05 | +1.8% | $221.02 | $229.18 | $217.18 | 1,356,300 | |
| $219.89 | +0.17 | +0.1% | $218.36 | $222.08 | $215.46 | 1,281,100 | |
| $219.72 | -11.46 | -5.0% | $231.31 | $231.36 | $219.40 | 1,661,700 | |
| $231.18 | -15.56 | -6.3% | $248.21 | $251.71 | $230.06 | 2,017,300 | |
| $246.74 | -7.33 | -2.9% | $253.68 | $254.44 | $246.66 | 1,044,400 | |
| $254.07 | -1.29 | -0.5% | $254.86 | $257.27 | $251.02 | 786,900 | |
| $255.36 | -0.60 | -0.2% | $256.28 | $256.60 | $248.12 | 1,147,900 | |
| $255.96 | +6.37 | +2.6% | $248.39 | $256.66 | $247.51 | 1,084,500 | |
| $249.59 | +3.08 | +1.2% | $246.51 | $251.81 | $245.52 | 933,700 | |
| $246.51 | -5.14 | -2.0% | $249.99 | $253.81 | $245.34 | 1,481,700 | |
| $251.65 | +7.33 | +3.0% | $246.86 | $255.51 | $244.13 | 1,131,800 | |
| $244.32 | +4.76 | +2.0% | $240.37 | $247.10 | $237.97 | 1,152,700 | |
| $239.56 | -5.95 | -2.4% | $246.41 | $246.49 | $238.51 | 2,755,000 | |
| $245.51 | +6.15 | +2.6% | $242.60 | $245.63 | $239.50 | 1,006,500 | |
| $239.36 | +1.09 | +0.5% | $239.50 | $242.24 | $236.00 | 853,700 | |
| $238.27 | -11.72 | -4.7% | $246.99 | $247.43 | $237.44 | 2,175,100 | |
| $249.99 | +1.31 | +0.5% | $250.17 | $252.79 | $244.18 | 997,200 | |
| $248.68 | +1.17 | +0.5% | $248.05 | $254.08 | $246.01 | 1,177,300 | |
| $247.51 | -10.49 | -4.1% | $256.68 | $256.68 | $246.42 | 1,625,900 | |
| $258.00 | -2.10 | -0.8% | $257.07 | $261.98 | $253.28 | 1,426,300 | |
| $260.10 | -6.01 | -2.3% | $259.00 | $272.08 | $254.01 | 2,008,500 | |
| $266.11 | +1.61 | +0.6% | $258.58 | $266.85 | $258.02 | 1,430,900 | |
| $264.50 | -2.90 | -1.1% | $265.94 | $271.19 | $261.54 | 1,709,100 | |
| $267.40 | +21.29 | +8.7% | $246.48 | $269.94 | $246.48 | 3,286,200 | |
| $246.11 | +5.42 | +2.3% | $242.40 | $248.13 | $238.00 | 1,941,200 | |
| $240.69 | +3.59 | +1.5% | $235.94 | $243.02 | $233.33 | 1,636,200 | |
| $237.10 | +0.54 | +0.2% | $224.47 | $239.08 | $223.61 | 1,847,000 | |
| $236.56 | -2.44 | -1.0% | $236.56 | $238.00 | $230.46 | 1,293,200 | |
| $239.00 | -1.08 | -0.4% | $238.54 | $242.89 | $236.60 | 1,116,200 | |
| $240.08 | +4.07 | +1.7% | $236.56 | $240.67 | $235.41 | 1,576,200 | |
| $236.01 | -0.21 | -0.1% | $235.83 | $237.91 | $228.59 | 2,134,900 | |
| $236.22 | +6.92 | +3.0% | $228.88 | $238.97 | $228.34 | 1,902,200 | |
| $229.30 | -13.31 | -5.5% | $239.00 | $240.88 | $228.74 | 1,701,700 | |
| $242.61 | +14.00 | +6.1% | $234.36 | $244.03 | $233.40 | 1,879,100 | |
| $228.61 | +4.01 | +1.8% | $226.27 | $230.91 | $222.01 | 1,600,200 | |
| $224.60 | -4.05 | -1.8% | $225.76 | $227.99 | $222.12 | 1,539,200 | |
| $228.65 | +1.53 | +0.7% | $223.52 | $228.98 | $220.23 | 1,525,800 | |
| $227.12 | +3.17 | +1.4% | $225.95 | $227.54 | $222.70 | 1,449,400 | |
| $223.95 | +2.75 | +1.2% | $219.00 | $224.66 | $219.00 | 1,621,200 | |
| $221.20 | +4.22 | +1.9% | $217.41 | $223.44 | $216.50 | 1,438,200 | |
| $216.98 | -2.22 | -1.0% | $218.00 | $223.50 | $215.61 | 1,404,800 | |
| $219.20 | +3.08 | +1.4% | $217.31 | $219.64 | $210.49 | 1,735,900 | |
| $216.12 | -12.60 | -5.5% | $228.58 | $234.00 | $212.98 | 2,274,600 | |
| $228.72 | +9.72 | +4.4% | $221.74 | $229.65 | $221.50 | 2,734,600 | |
| $219.00 | -1.33 | -0.6% | $220.33 | $222.59 | $215.07 | 3,107,600 | |
| $220.33 | +14.81 | +7.2% | $208.04 | $220.49 | $208.04 | 3,399,800 |
- Ticker
- BX Swiss:DUL
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BX Swiss
- Currency
- CHF
What changed lately
Latest news release · Nov 3, 2026
Alnylam to Present Five-Year HELIOS-B Data and Expanding Evidence on the Benefits of RNAi-Powered TTR Silencing with AMVUTTRA® (vutrisiran) at AHA and ISA 2026
Latest earnings call · Oct 29, 2026
Alnylam Pharmaceuticals (NASDAQ:ALNY) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Oct 29, 2026
Q3 2026 Earnings Presentation
Earnings · 33 slides
Calls
Replays
Alnylam Pharmaceuticals (NASDAQ:ALNY) Q3 2026 Earnings Call
Thu, Oct 29, 2026 · 8:30 AM ET
Watch TranscriptAlnylam Pharmaceuticals (NASDAQ:ALNY) Q2 2026 Earnings Call
Thu, Jul 30, 2026 · 8:30 AM ET
Watch TranscriptAlnylam Pharmaceuticals (NASDAQ:ALNY) Q1 2026 Earnings Call
Thu, Apr 30, 2026 · 8:30 AM ET
Watch Transcript
Latest news
Alnylam Pharmaceuticals Reports Third Quarter 2026 Financial Results and Highlights Recent Period Progress
Oct 29, 2026
Closed $174.00 (-25.1%) on Oct 29, 2026
Alnylam Announces Positive Initial Phase 1b Data for Brezosiran (ALN-HTT02) Demonstrating Deep and Durable Huntingtin Lowering in Huntington’s Disease
Oct 23, 2026
Closed $224.03 (-1.4%) on Oct 23, 2026
Alnylam to Webcast Conference Call Discussing Third Quarter 2026 Financial Results
Oct 15, 2026
Closed $234.03 (+4.3%) on Oct 15, 2026
AMVUTTRA® (vutrisiran) ‘Play by Play’ Initiative Highlights Former Athletes’ Stories to Shine a Light on the Often-Missed Signs of ATTR-CM
Sep 29, 2026
Closed $254.07 (-0.5%) on Sep 29, 2026
Alnylam Presents New Data at ESC Congress 2026 Reinforcing Strength in RNAi-Powered TTR Silencing Across ATTR-CM Patient Populations and Treatment Settings
Aug 30, 2026
Closed $240.69 (+1.5%) on Aug 31, 2026
Alnylam to Present New Data Reinforcing Strength in RNAi-Powered TTR Silencing and Continued Progress in Hypertension at ESC Congress 2026
Aug 24, 2026
Closed $236.01 (-0.1%) on Aug 24, 2026
Alnylam Pharmaceuticals Reports Second Quarter 2026 Financial Results and Highlights Recent Period Progress
Jul 30, 2026
Closed $205.48 (-28.3%) on Jul 30, 2026
Alnylam to Webcast Conference Call Discussing Second Quarter 2026 Financial Results
Jul 16, 2026
Closed $283.15 (+1.4%) on Jul 16, 2026
Alnylam Highlights Progress with Neuroscience Programs at AAIC 2026, Showcasing Potential of RNAi in Neurological Disease
Jul 15, 2026
Closed $279.14 (-0.8%) on Jul 15, 2026
Decks
Q3 2026 Earnings Presentation
Earnings · 33 slides · Oct 29, 2026
Technical Presentation (October 2026)
Technical · 69 slides · Oct 26, 2026
Technical Presentation (October 2026)
Technical · 17 slides · October 2026
Technical Presentation (September 2026)
Technical · 55 slides · Sep 17, 2026
Alnylam Pharmaceuticals, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 41 in the last 12 months · 293 in all · newest Nov 3, 2026 · oldest 2019
- Calls
- 25 calls with a replay · 25 with a transcript · latest Oct 29, 2026
- Decks
- 89 decks · latest Oct 29, 2026
Where Alnylam Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ALNY · Home listing | NASDAQ | United States | USD |
| gettex:DUL | gettex | Germany | EUR |
| LS Exchange:A0CBCK | LS Exchange | Germany | EUR |
| Tradegate:DUL | Tradegate | Germany | EUR |
| B3:A1LN34 | B3 | Brazil | BRL |
| BMV:ALNY | BMV | Mexico | MXN |
| Lang & Schwarz:A0CBCK | Lang & Schwarz | Germany | EUR |
| Xetra:DUL | Xetra | Germany | EUR |
| LSE:0HD2 | LSE | United Kingdom | USD |
| Frankfurt:DUL | Frankfurt | Germany | EUR |
| Milan:1ALNY | Milan | Italy | EUR |
| BIVA:ALNY | BIVA | Mexico | MXN |
| BOATS:ALNY | BOATS | United States | USD |
| Dusseldorf:DUL | Dusseldorf | Germany | EUR |
| Hamburg:DUL | Hamburg | Germany | EUR |
| Hanover:DUL | Hanover | Germany | EUR |
| Munich:DUL | Munich | Germany | EUR |
| BX Swiss:DUL · This page | BX Swiss | Switzerland | CHF |
| Stuttgart:DUL | Stuttgart | Germany | EUR |
| VIE:ALNY | Vienna | Austria | EUR |
Log in to ask 6ix AI your own questions about Alnylam Pharmaceuticals, Inc.